Given the wide variety of cardiopathologies in which both EGR1 and MEF2 have been implicated, further investigation of EGR1’s function as a potent MEF2 repressor will provide additional insight into mechanisms of various cardiopathologies and into potential targets for treatment of cardiac disease. Here, EGR1 is linked to heart disorder.